Authors:
Gloyn, AL
Hashim, Y
Ashcroft, SJH
Ashfield, R
Wiltshire, S
Turner, RC
Citation: Al. Gloyn et al., Association studies of variants in promoter and coding regions of beta-cell ATP-sensitive K-channel genes SUR1 and Kir6.2 with Type 2 diabetes mellitus (UKPDS 53), DIABET MED, 18(3), 2001, pp. 206-212
Authors:
Van Fossan, D
Jagoda, L
LeSage, A
Hartmann, R
Johl, J
Sharman, J
Jay, M
Schnurr, D
Crawford-Miksza, L
Glaser, C
Vugia, D
Leach, R
Cantiello, K
Auer, P
Jones, G
Qian, J
Depowski, P
Downing, P
Trimarchi, C
Huang, C
Drabkin, P
Eidson, M
Wallace, B
Willsey, A
Smith, P
Ahadzie, L
Katner, HP
Rahman, M
Muraina, O
Tift, JP
Shetty, D
Drenzek, CL
Lance-Parker, S
Cantrell, D
Saidla, E
Koppanyi, Z
Blake, PA
Boldingh, T
Wagstrom, L
Danila, R
Mariotti, J
Smith, KE
Neitzel, D
Hull, HF
Shireley, L
Johnson, D
Patron, R
Scheckler, WE
Levin, JM
Dominski, M
Wolff, M
Muhlenbeck, B
Turner, RC
Kazmierczak, J
Proctor, M
Davis, JP
Citation: D. Van Fossan et al., Human rabies - California, Georgia, Minnesota, New York, and Wisconsin, 2000 (Reprinted from MMWR, vol 49, pg 1111-1115, 2000), J AM MED A, 285(2), 2001, pp. 158-160
Authors:
Stratton, IM
Kohner, EM
Aldington, SJ
Turner, RC
Holman, RR
Manley, SE
Matthews, DR
Citation: Im. Stratton et al., UKPDS 50: Risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis, DIABETOLOG, 44(2), 2001, pp. 156-163
Authors:
Stratton, IM
Adler, AI
Neil, HAW
Matthews, DR
Manley, SE
Cull, CA
Hadden, D
Turner, RC
Holman, RR
Citation: Im. Stratton et al., Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study, BR MED J, 321(7258), 2000, pp. 405-412
Authors:
Adler, AI
Stratton, IM
Neil, HAW
Yudkin, JS
Matthews, DR
Cull, CA
Wright, AD
Turner, RC
Holman, RR
Citation: Ai. Adler et al., Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study, BR MED J, 321(7258), 2000, pp. 412-419
Authors:
Widjaja, A
Levy, JC
Morris, RJ
Frayn, KN
Humphreys, SM
Horn, R
von zur Muhlen, A
Turner, RC
Brabant, G
Citation: A. Widjaja et al., Determinants of within-subject variation of fasting serum leptin concentrations in healthy subjects, EXP CL E D, 108(3), 2000, pp. 208-213
Authors:
Manley, SE
Stratton, IM
Cull, CA
Frighi, V
Eeley, EA
Matthews, DR
Holman, RR
Turner, RC
Neil, HAW
Citation: Se. Manley et al., Effects of three months' diet after diagnosis of Type 2 diabetes on plasmalipids and lipoproteins (UKPDS 45), DIABET MED, 17(7), 2000, pp. 518-523
Authors:
MacNamara, CM
Barrow, BA
Manley, SE
Levy, JC
Clark, A
Turner, RC
Citation: Cm. Macnamara et al., Parallel changes of proinsulin and islet amyloid polypeptide in glucose intolerance, DIABET RE C, 50(2), 2000, pp. 117-126
Citation: Aj. Farmer et al., Knowledge of risk of developing diabetes mellitus among siblings of Type 2diabetic patients, DIABET MED, 16(3), 1999, pp. 233-237
Citation: Rr. Holman et al., A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (UK Prospective Diabetes Study 44), DIABET CARE, 22(6), 1999, pp. 960-964
Citation: Rr. Holman et al., A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (vol 22, pg 960, 1999), DIABET CARE, 22(11), 1999, pp. 1922-1922
Citation: Rc. Turner, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2diabetes (UKPDS 33) (vol 352, pg 837, 1998), LANCET, 354(9178), 1999, pp. 602-602
Citation: Rc. Turner et al., Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus - Progressive requirement for multiple therapies (UKPDS 49), J AM MED A, 281(21), 1999, pp. 2005-2012
Citation: Mp. Hermans et al., Comparison of insulin sensitivity tests across a range of glucose tolerance from normal to diabetes, DIABETOLOG, 42(6), 1999, pp. 678-687
Citation: Jte. Shaw et al., The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus, DIABETOLOG, 42(1), 1999, pp. 24-27
Citation: Mp. Hermans et al., Comparison of tests of B-cell function across a range of glucose tolerancefrom normal to diabetes, DIABETES, 48(9), 1999, pp. 1779-1786
Authors:
Frayling, TM
Walker, M
McCarthy, MI
Evans, JC
Allen, LI
Lynn, S
Ayres, S
Millauer, B
Turner, C
Turner, RC
Sampson, MJ
Hitman, GA
Ellard, S
Hattersley, AT
Citation: Tm. Frayling et al., Parent-offspring trios - A resource to facilitate the identification of type 2 diabetes genes, DIABETES, 48(12), 1999, pp. 2475-2479
Authors:
Widjaja, A
Morris, RJ
Levy, JC
Frayn, KN
Manley, SE
Turner, RC
Citation: A. Widjaja et al., Within- and between-subject variation in commonly measured anthropometric and biochemical variables, CLIN CHEM, 45(4), 1999, pp. 561-566
Authors:
Davis, TME
Millns, H
Stratton, IM
Holman, RR
Turner, RC
Citation: Tme. Davis et al., Risk factors for stroke in type 2 diabetes mellitus - United Kingdom prospective diabetes study (UKPDS) 29, ARCH IN MED, 159(10), 1999, pp. 1097-1103
Authors:
Adler, AI
Neil, AW
Manley, SE
Holman, RR
Turner, RC
Citation: Ai. Adler et al., Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47), AM HEART J, 138(5), 1999, pp. S353-S359
Citation: Jte. Shaw et al., The relationship between the insulin resistance syndrome and insulin sensitivity in the first-degree relatives of subjects with non-insulin dependentdiabetes mellitus, DIABET RE C, 42(2), 1998, pp. 91-99